blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1646629

EP1646629 - CYCLOPROPYL GROUP SUBSTITUTED OXAZOLIDINONE ANTIBIOTICS AND DERIVATIVES THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  29.04.2011
Database last updated on 24.04.2024
Most recent event   Tooltip11.10.2013Lapse of the patent in a contracting state
New state(s): ES		published on 13.11.2013  [2013/46]
Applicant(s)For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
For all designated states
Kyorin Pharmaceutical Co., Ltd.
5, Kanda Surugadai 2-chome, Chiyoda-ku
Tokyo 101-8311 / JP
[2010/25]
Former [2010/10]For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
For all designated states
KYORIN PHARMACEUTICAL CO., LTD.
5, Kanda Surugadai 2-chome, Chiyoda-ku
Tokyo 101-8311 / JP
Former [2006/16]For all designated states
Merck & Co., Inc.
P.O. Box 2000 Rahway
New Jersey 07065 / US
For all designated states
KYORIN PHARMACEUTICAL CO., LTD.
5, Kanda Surugadai 2-chome, Chiyoda-ku
Tokyo 101-8311 / JP
Inventor(s)01 / FUKUDA, Yasumichi
33-2, Utsukusigaoka 3-chome, Oyama
Tochigi 329-0207 / JP
 [2006/16]
Representative(s)Gillard, Richard Edward
Elkington and Fife LLP
Thavies Inn House
3-4 Holborn Circus
London EC1N 2HA / GB
[N/P]
Former [2009/45]Gillard, Richard Edward
Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus
London EC1N 2HA / GB
Former [2006/16]Gillard, Richard Edward
Elkington and Fife LLP, Prospect House 8 Pembroke Road Sevenoaks
Kent TN13 1XR / GB
Application number, filing date04777196.929.06.2004
[2006/16]
WO2004US20734
Priority number, dateUS20030483904P02.07.2003         Original published format: US 483904 P
US20040546984P24.02.2004         Original published format: US 546984 P
[2006/16]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005005398
Date:20.01.2005
Language:EN
[2005/03]
Type: A2 Application without search report 
No.:EP1646629
Date:19.04.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 20.01.2005 takes the place of the publication of the European patent application.
[2006/16]
Type: B1 Patent specification 
No.:EP1646629
Date:23.06.2010
Language:EN
[2010/25]
Search report(s)International search report - published on:EP28.04.2005
ClassificationIPC:C07D413/14
[2006/16]
CPC:
C07D413/10 (EP,KR,US); C07D413/14 (EP,KR,US); A61P17/08 (EP);
A61P25/02 (EP); A61P25/08 (EP); A61P3/02 (EP);
A61P31/04 (EP); A61P31/06 (EP); A61P7/02 (EP);
A61P7/06 (EP); C07D417/14 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/16]
Extension statesAL11.01.2006
HRNot yet paid
LT11.01.2006
LV11.01.2006
MK11.01.2006
TitleGerman:CYCLOPROPYLGRUPPENSUBSTITUIERTE OXAZOLIDINONANTIBIOTIKA UND DERIVATE DAVON[2006/16]
English:CYCLOPROPYL GROUP SUBSTITUTED OXAZOLIDINONE ANTIBIOTICS AND DERIVATIVES THEREOF[2006/16]
French:ANTIBIOTIQUES A BASE D'OXAZOLIDINONE SUBSTITUEE PAR UN GROUPE CYCLIPROPYL ET DERIVES[2006/16]
Entry into regional phase11.01.2006National basic fee paid 
11.01.2006Designation fee(s) paid 
11.01.2006Examination fee paid 
Examination procedure17.05.2005Request for preliminary examination filed
International Preliminary Examining Authority: EP
11.01.2006Examination requested  [2006/16]
12.01.2007Amendment by applicant (claims and/or description)
11.06.2007Despatch of a communication from the examining division (Time limit: M06)
26.11.2007Reply to a communication from the examining division
23.07.2008Despatch of a communication from the examining division (Time limit: M06)
22.12.2008Reply to a communication from the examining division
09.12.2009Communication of intention to grant the patent
19.04.2010Fee for grant paid
19.04.2010Fee for publishing/printing paid
Opposition(s)24.03.2011No opposition filed within time limit [2011/22]
Fees paidRenewal fee
11.01.2006Renewal fee patent year 03
27.06.2007Renewal fee patent year 04
25.06.2008Renewal fee patent year 05
26.06.2009Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT23.06.2010
BE23.06.2010
CY23.06.2010
CZ23.06.2010
DK23.06.2010
EE23.06.2010
FI23.06.2010
IT23.06.2010
NL23.06.2010
PL23.06.2010
RO23.06.2010
SE23.06.2010
SI23.06.2010
SK23.06.2010
TR23.06.2010
IE29.06.2010
LU29.06.2010
MC30.06.2010
BG23.09.2010
GR24.09.2010
ES04.10.2010
PT25.10.2010
HU24.12.2010
[2013/46]
Former [2013/42]AT23.06.2010
BE23.06.2010
CY23.06.2010
CZ23.06.2010
DK23.06.2010
EE23.06.2010
FI23.06.2010
IT23.06.2010
NL23.06.2010
PL23.06.2010
RO23.06.2010
SE23.06.2010
SI23.06.2010
SK23.06.2010
TR23.06.2010
IE29.06.2010
LU29.06.2010
MC30.06.2010
BG23.09.2010
GR24.09.2010
PT25.10.2010
HU24.12.2010
Former [2012/47]AT23.06.2010
BE23.06.2010
BG23.06.2010
CY23.06.2010
CZ23.06.2010
DK23.06.2010
EE23.06.2010
FI23.06.2010
IT23.06.2010
NL23.06.2010
PL23.06.2010
RO23.06.2010
SE23.06.2010
SI23.06.2010
SK23.06.2010
TR23.06.2010
IE29.06.2010
LU29.06.2010
MC30.06.2010
GR24.09.2010
PT25.10.2010
HU24.12.2010
Former [2012/43]AT23.06.2010
BE23.06.2010
BG23.06.2010
CY23.06.2010
CZ23.06.2010
DK23.06.2010
EE23.06.2010
FI23.06.2010
IT23.06.2010
NL23.06.2010
PL23.06.2010
RO23.06.2010
SE23.06.2010
SI23.06.2010
SK23.06.2010
IE29.06.2010
LU29.06.2010
MC30.06.2010
GR24.09.2010
PT25.10.2010
HU24.12.2010
Former [2012/42]AT23.06.2010
BE23.06.2010
BG23.06.2010
CY23.06.2010
CZ23.06.2010
DK23.06.2010
EE23.06.2010
FI23.06.2010
IT23.06.2010
NL23.06.2010
PL23.06.2010
RO23.06.2010
SE23.06.2010
SI23.06.2010
SK23.06.2010
IE29.06.2010
MC30.06.2010
GR24.09.2010
PT25.10.2010
HU24.12.2010
Former [2012/41]AT23.06.2010
BE23.06.2010
BG23.06.2010
CY23.06.2010
CZ23.06.2010
DK23.06.2010
EE23.06.2010
FI23.06.2010
IT23.06.2010
NL23.06.2010
PL23.06.2010
RO23.06.2010
SE23.06.2010
SI23.06.2010
SK23.06.2010
IE29.06.2010
MC30.06.2010
GR24.09.2010
PT25.10.2010
Former [2011/19]AT23.06.2010
BE23.06.2010
CY23.06.2010
CZ23.06.2010
DK23.06.2010
EE23.06.2010
FI23.06.2010
IT23.06.2010
NL23.06.2010
PL23.06.2010
RO23.06.2010
SE23.06.2010
SI23.06.2010
SK23.06.2010
IE29.06.2010
MC30.06.2010
GR24.09.2010
PT25.10.2010
Former [2011/15]AT23.06.2010
BE23.06.2010
CY23.06.2010
CZ23.06.2010
EE23.06.2010
FI23.06.2010
IT23.06.2010
NL23.06.2010
PL23.06.2010
RO23.06.2010
SE23.06.2010
SI23.06.2010
SK23.06.2010
MC30.06.2010
GR24.09.2010
PT25.10.2010
Former [2011/13]AT23.06.2010
BE23.06.2010
CY23.06.2010
CZ23.06.2010
EE23.06.2010
FI23.06.2010
NL23.06.2010
PL23.06.2010
RO23.06.2010
SE23.06.2010
SI23.06.2010
SK23.06.2010
MC30.06.2010
GR24.09.2010
PT25.10.2010
Former [2011/11]AT23.06.2010
CZ23.06.2010
EE23.06.2010
FI23.06.2010
NL23.06.2010
PL23.06.2010
RO23.06.2010
SE23.06.2010
SI23.06.2010
SK23.06.2010
MC30.06.2010
GR24.09.2010
PT25.10.2010
Former [2011/08]AT23.06.2010
EE23.06.2010
FI23.06.2010
NL23.06.2010
PL23.06.2010
SE23.06.2010
SI23.06.2010
MC30.06.2010
GR24.09.2010
Former [2011/07]AT23.06.2010
FI23.06.2010
NL23.06.2010
PL23.06.2010
SE23.06.2010
SI23.06.2010
MC30.06.2010
GR24.09.2010
Former [2011/04]AT23.06.2010
FI23.06.2010
PL23.06.2010
SE23.06.2010
SI23.06.2010
GR24.09.2010
Former [2011/01]AT23.06.2010
FI23.06.2010
SE23.06.2010
SI23.06.2010
GR24.09.2010
Former [2010/51]AT23.06.2010
FI23.06.2010
SE23.06.2010
SI23.06.2010
Cited inInternational search[DA]EP0352781  (DU PONT [US]) [DA] 1,2,7,8,10-15 * example 38 *;
 [X]WO9413649  (UPJOHN CO [US], et al) [X] 1,2,7,8,10-15 * claim 1 * * page 64, line 20 - line 21 * * page 64, line 26 - line 27 *;
 [X]US5523403  (BARBACHYN MICHAEL R [US]) [X] 1,2,7,8,10-15 * claim 1 * * column 46, line 1 - line 3 * * column 46, line 10 - line 12 *;
 [A]US5736545  (GADWOOD ROBERT C [US], et al) [A] 1,2,7,8,10-15* column 1, line 43 - column 2, line 14 *;
 [DX]WO0194342  (DONG A PHARM CO LTD [KR], et al) [DX] 1,2,7,8,10-15 * claim - * * examples 42,78,119,129,132,134,136,139,143,146,148 *;
 [A]WO03027083  (MERCK & CO INC [US], et al) [A] 1-15 * claim - *;
 [PX]WO2004048350  (ASTRAZENECA AB [SE], et al) [PX] 1,2,7,8,10-15 * page 78, line 24 - page 79; claim 1 * * example 8 *;
 [E]US2004147760  (THOMAS RICHARD CHARLES [US], et al) [E] 1,2,7,8,10-15 * examples 48-51,54-57,65,72,73 * * claim 70 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.